<DOC>
	<DOCNO>NCT00001622</DOCNO>
	<brief_summary>A layer cell call endothelium line wall blood vessel . These cell produce substance control tone blood vessel thus control blood flow vessel . One substance produce involve control blood vessel function nitric oxide . Nitric oxide ( NO ) play role relaxation blood vessel . Researchers interested function endothelium patient high blood pressure ( essential hypertension ) patient high cholesterol ( hypercholesterolemia ) . After conduct study endothelium nitric oxide , researcher find endothelium indeed function abnormally patient high blood pressure high cholesterol . In addition , researcher determine dysfunction result abnormality nitric oxide ( NO ) system . In study researcher plan investigate relationship blood vessel responses real-life setting versus laboratory setting normal volunteer , patient high blood pressure , patient high cholesterol .</brief_summary>
	<brief_title>Study Response Human Small Blood Vessels</brief_title>
	<detailed_description>Over last ten year , interested investigation endothelial function patient essential hypertension patient hypercholesterolemia . We perform intra-arterial infusion endothelium-dependent endothelium-independent drug brachial artery noninvasive measurement response forearm vasculature mean strain gauge plethysmography . Those study allow u : ) demonstrate presence endothelial dysfunction patient essential hypertension patient hypercholesterolemia ; b ) identify abnormality endothelium-derived nitric oxide system responsible endothelial dysfunction patient . Further study precisely determine intracellular process mediate abnormality endothelial function patient limited inherent shortcoming vivo technique . An alternative possibility study human small vessel vitro ; however , relationship vivo vitro vascular response endothelium-dependent -independent agonist establish . In present study , propose investigate relationship normal volunteer , patient essential hypertension , patient hypercholesterolemia .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Patients ( men nonpregnant woman ) systemic hypertension , patient hypercholesterolemia , normal volunteer . All blood pressure recording must consistently elevate . No renovascular hypertension etiology elevate blood pressure . No definite evidence accelerate malignant hypertension ( diastolic pressure 115 mmHg , associate encephalopathic change , papilledema , progressive renal failure , congestive heart failure ) , serious intercurrent illness . Patients withdrawal antihypertensive medication consider hazardous ineligible . Patients blood pressure remain normal level 2 week withdrawal antihypertensive treatment closely monitor become hypertensive , time undergo study . Patients blood pressure increase 2 month discontinuation therapy exclude study . Patients coexistent hypertension hypercholesterolemia ineligible . Normal volunteer take kind medication eligible . No history diabetes , peripheral vascular disease , coagulopathy , disease predispose vasculitis Raynaud 's phenomenon . No history keloid formation . All patient must capable give informed consent procedure .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>Endothelium</keyword>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Microvessels</keyword>
	<keyword>Vasodilation</keyword>
	<keyword>Normal Volunteer</keyword>
</DOC>